Future Horizons in the UK Cancer Diagnostics Market: SupplierShares and Sales Forecasts for 40 Tumor Markers by MarketSegm...
Major points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology OverviewA. Can...
23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5-Nucleoti...
30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma...
- Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Inter...
- RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tach...
23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista...
- QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. A...
6. Major Types of Distributors7. Market Segmentation Factor Potential Market Entry Barriers and RisksA. Market MaturityB. ...
- OncoLab- Otho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen- Radient Pharmaceut...
CEA TestsMajor Companies Developing or MarketingEstrogen Receptor TestsMajor Companies Developing or MarketingProgesterone...
Tumor Marker Test Volume and SalesForecast by Market SegmentU.K., Estimated Cancer Death RatesPer 100,000 PopulationU.K., ...
Sales Forecast by Market SegmentU.K., CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Calcitonin T...
Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Smear Test Volume and DiagnosticsSales Forecast by Ma...
Contact: sales@reportsandreports.com for more information.
Upcoming SlideShare
Loading in …5
×

Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

193 views
172 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
193
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

  1. 1. Future Horizons in the UK Cancer Diagnostics Market: SupplierShares and Sales Forecasts for 40 Tumor Markers by MarketSegmentReport Details:Published:August 2012No. of Pages: 575Price: Single User License – US$5400Highlights•Comprehensive 575-page analysis of the UK tumor marker testing market.•Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.•Ten-year test volume and sales forecasts over for 40 tumor marker performed in UK hospitals, commercial laboratories and physician offices.•Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.•Current instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 575 pages and 85 tablesGet your copy of this report @http://www.reportsnreports.com/reports/187740-future-horizons-in-the-uk-cancer-diagnostics-market-supplier-shares-and-sales-forecasts-for-40-tumor-markers-by-market-segment.html
  2. 2. Major points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology OverviewA. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer12. Bladder CancerB. Major Current And Emerging Cancer Diagnostic Tests1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes
  3. 3. 23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5-Nucleotidase27. Oncogenes- Abl/abl-bcr- AIB1- BCL-2- BRCA1- CD44- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51- P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src28. Polypeptide Growth Factors- Basic Fibroblast Growth Factor- Beta-TGF- Cachectin (TNT)- Calmodulin- ECFR- Nerve Growth Factor (NGF)- Epidermal Growth Factor (EGF)- Ornithine Decarboxylase- Transferrin- Transforming Growth Factor-Alpha29. Ectopic Hormones
  4. 4. 30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma-Interferon- Interleukin-1 (IL-1)- Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers- N-Acetylglucosamine- Actin- Alpha-Actin- Antineuronal Antibodies- 7B2- B72.3- Bax- BCD-F9- BLCA-4- Blood Group Antigens A,B,H- CA 50- CA 72-4/TAG-72- CA 195- CA-242- CA-549- CAM 26- CAR-3- Cathepsin-D- Chromogranin A and B- Cluster 1 Antigen- Cluster-5/5A Antigen- CTA- CU18- DR-70- DU-PAN-2- Endometrial Bleeding Associated Factor- Endostatin- Epithelial Membrane Antigen- Feulgen Hydrolysis- Fibronectin- FSH- (1->3)-L-fucosyltransferase
  5. 5. - Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Intermediate Filaments- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1- Minactivin- MN/CA9- MSA- Mucin Cancer Antigen (MCA)- Multiple Tumor Suppressor 1- Myosin- NEA-130- NMP22- OA-519- Opiod Peptides- P-glycoprotein- Pancreatic Oncofetal Antigen (POA)- Placental Lactogen- PR92- Proliferative Index, Ki-67- Px
  6. 6. - RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tachykinin- TAG 12- TPS- Troponin- Tubulin- VCAM- VEGF- VillenC. Instrumentation Review And Market Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys
  7. 7. 23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)- Overview- ELISA- Immunofiltration- Particle-Membrane Capture Immunoassay- Enzyme Amplificationd. Fluorescent Immunoassayse. Luminescence- Chemiluminescence- Bioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification Methods- PCR- DAP-PCR- Immuno-PCR- QC-PCR- CAR- DNA- HPA- LCR- NASBA
  8. 8. - QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant Lymphomas Lymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyE. Personal TestingU.K.A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major Suppliers Major Product Development OpportunitiesA. Reagent Kits and Test Systems/PanelsB. InstrumentationC. Computers, Software and AutomationD. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative MarketPenetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers
  9. 9. 6. Major Types of Distributors7. Market Segmentation Factor Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Profiles- Abbott- AdnaGen- Applied Gene Technologies- Arca- Beckman Coulter/Danaher- Becton Dickinson- Biomedical Diagnostics- bioMerieux- Bio-Rad- Cepheid- Correlogic Systems- Dako- Decode- Diadexus- Diagnocure- Diasorin- Eiken Chemical- Enterix- Enzo Biochem- Epigenomics- Exact Sciences- Fujirebio- Gen-Probe- Guided Therapeutics- Hologic- Ipsogen- Kreatech- Kyowa Medex- Life Technologies- Mackay Life Sciences- Myriad Genetics- Nanogen Elitech
  10. 10. - OncoLab- Otho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen- Radient Pharmaceuticals- Roche- Scienion- Sequenom- Siemens Healthcare- Takara Bio- Targeted Diagnostics & Therapeutics- Tosoh- Veridex- Wako Pure Chemicals- Wallac/PE- ZilaAppendixesAppendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technologyand ApplicationsAppendix II: Assumed Currency Exchange RatesList of TablesTumor Marker ClassificationMajor Companies Developing or MarketingACTH TestsMajor Companies Developing or MarketingAFP TestsMajor Companies Developing or MarketingBeta-2 Microglobulin TestsMajor Companies Developing or MarketingCA 15-3/27.29 TestsMajor Companies Developing or MarketingCA 19-9 TestsMajor Companies Developing or MarketingCA 125 TestsMajor Companies Developing or MarketingCalcitonin TestsMajor Companies Developing or Marketing
  11. 11. CEA TestsMajor Companies Developing or MarketingEstrogen Receptor TestsMajor Companies Developing or MarketingProgesterone Receptor TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingGastrin TestsList of Tables (continued)Major Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingInsulin TestsMajor Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingPAP Smear/HPV TestsMajor Companies Developing or MarketingPAP TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingLymphocyte Subclassification TestsBiochemical Markers Potential ApplicationsIn Cancer DiagnosisOncogenes Potential ApplicationsIn Cancer DiagnosisMajor Companies Developing or MarketingOncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in Cancer DiagnosisLymphokines Potential ApplicationsIn Cancer DiagnosisList of Tables (continued)Immunohistochemical Stains PotentialApplications in Cancer DiagnosisExecutive Summary Table: U.K., Total
  12. 12. Tumor Marker Test Volume and SalesForecast by Market SegmentU.K., Estimated Cancer Death RatesPer 100,000 PopulationU.K., Laboratories Performing TumorMarker Tests by Market SegmentU.K., Hospital Laboratories PerformingTumor Marker Tests by Bed SizeU.K., Commercial/Private LaboratoriesPerforming Tumor Marker Tests byAnnual Test VolumeU.K., Total Tumor Marker Testing VolumeForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Test Volume ForecastU.K., Hospital Laboratories MajorTumor Marker Test Volume Forecast byTestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastU.K., Total Tumor Marker SalesForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Sales Forecast by TestList of Tables (continued)U.K., Hospital Laboratories MajorTumor Marker Sales Forecast by TestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast byTestU.K., ACTH Test Volume and Diagnostics SalesForecast by Market SegmentU.K., AFP Test Volume and Diagnostics SalesForecast by Market SegmentU.K., Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CA 19-9 Test Volume and Diagnostics
  13. 13. Sales Forecast by Market SegmentU.K., CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Calcitonin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CEA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Chromogranin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Colon-Specific Antigen Test VolumeAnd Diagnostics Sales by MarketSegmentList of Tables (continued)U.K., Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Ferritin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., NSE Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentList of Tables (continued)U.K., Pancreatic Oncofetal Antigen
  14. 14. Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Smear Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., PSA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Serotonin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Squamous Cell Carcinoma AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TDT Test Volume and DiagnosticsSales Forecast by Market SegmentList of Tables (continued)U.K., Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TPA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Total Tumor Marker Sales andMarket Shares ForecastU.K., CEA Testing Market DiagnosticsSales by Major SupplierU.K., PSA Testing Market DiagnosticsSales by Major Supplier
  15. 15. Contact: sales@reportsandreports.com for more information.

×